|
T cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
|
Cytokine Release Syndrome |
|
Enduring |
|
$25.00 |
|
Basic immunology: complement and hypersensitivities |
|
Enduring |
|
$25.00 |
|
Cancer Immunotherapies |
|
Enduring |
|
$350.00 |
|
An Introduction to Immuno-Safety Science |
|
Enduring |
|
$350.00 |
|
Definition, history and application of immunosafety in drug development |
|
Enduring |
|
$25.00 |
|
Diversity of immune responses (impact of age, sex, pregnancy, co-morbidities, etc.) |
|
Enduring |
|
$25.00 |
|
Diversity of immune responses (impact of age, sex, pregnancy, co-morbidities, etc.) |
|
Enduring |
|
$25.00 |
|
Assessing adversity in immunosafety (preclinical) |
|
Enduring |
|
$25.00 |
|
Neurotoxicity across Cancer Modalities |
|
Enduring |
|
$25.00 |
|
B cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
|
Assessing Risk of Adverse Pregnancy Outcomes for Immuno-Oncology Programs |
|
Enduring |
|
$25.00 |
|
Immunomodulating therapies (overview) |
|
Enduring |
|
$25.00 |
|
Overview of Cancer Immunotherapies |
|
Enduring |
|
$35.00 |
|
HESI Human health and Safety |
|
Enduring |
|
$0.00 |
Facebook
Twitter
LinkedIn
Forward